phthalic acid has been researched along with Dyslipidemia in 3 studies
phthalic acid: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7178
phthalic acid : A benzenedicarboxylic acid cosisting of two carboxy groups at ortho positions.
Excerpt | Relevance | Reference |
---|---|---|
" The goal of this study was to compare the urine levels of bisphenol A and phthalate metabolites in subgroups of patients with metabolic syndrome composed of patients with and without three important components of metabolic syndrome (hypertension, dyslipidemia and diabetes)." | 7.83 | Urine Levels of Phthalate Metabolites and Bisphenol A in Relation to Main Metabolic Syndrome Components: Dyslipidemia, Hypertension and Type 2 Diabetes. A Pilot Study. ( Haluzík, M; Lacinová, Z; Malý, M; Matějková, D; Matoulek, M; Mráz, M; Müllerová, D; Pavloušková, J; Piecha, R; Svačina, Š; Vavrouš, A; Vrbík, K, 2016) |
" The goal of this study was to compare the urine levels of bisphenol A and phthalate metabolites in subgroups of patients with metabolic syndrome composed of patients with and without three important components of metabolic syndrome (hypertension, dyslipidemia and diabetes)." | 3.83 | Urine Levels of Phthalate Metabolites and Bisphenol A in Relation to Main Metabolic Syndrome Components: Dyslipidemia, Hypertension and Type 2 Diabetes. A Pilot Study. ( Haluzík, M; Lacinová, Z; Malý, M; Matějková, D; Matoulek, M; Mráz, M; Müllerová, D; Pavloušková, J; Piecha, R; Svačina, Š; Vavrouš, A; Vrbík, K, 2016) |
" In adjusted models, the prevalence and RRs of dyslipidemia increased with tertile group of mono-n-butyl phthalate (MnBP), mono-2-ethyl-5-oxohexyl phthalate (MEOHP), mono-2-ethyl-5-hydroxyhexyl phthalate (MEHHP), and summed di-(2-ethylhexyl) phthalate (∑DEHP) metabolites with a dose-response relationship in visit 1, as well as persistent dyslipidemia." | 1.72 | Association between urinary phthalate metabolites and dyslipidemia in children: Results from a Chinese cohort study. ( Chen, L; Chen, M; Dong, Y; Gao, D; Li, Y; Ma, J; Ma, Y; Wang, X; Yang, Z; Zou, Z, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Gao, D | 1 |
Zou, Z | 1 |
Li, Y | 1 |
Chen, M | 1 |
Ma, Y | 1 |
Chen, L | 1 |
Wang, X | 1 |
Yang, Z | 1 |
Dong, Y | 1 |
Ma, J | 1 |
Kim, B | 1 |
Park, B | 2 |
Kim, CH | 1 |
Kim, S | 1 |
Piecha, R | 1 |
Svačina, Š | 1 |
Malý, M | 1 |
Vrbík, K | 1 |
Lacinová, Z | 1 |
Haluzík, M | 1 |
Pavloušková, J | 1 |
Vavrouš, A | 1 |
Matějková, D | 1 |
Müllerová, D | 1 |
Mráz, M | 1 |
Matoulek, M | 1 |
3 other studies available for phthalic acid and Dyslipidemia
Article | Year |
---|---|
Association between urinary phthalate metabolites and dyslipidemia in children: Results from a Chinese cohort study.
Topics: Child; Cohort Studies; Dyslipidemias; Environmental Exposure; Environmental Pollutants; Female; Huma | 2022 |
Association between endocrine-disrupting chemical mixture and metabolic indices among children, adolescents, and adults: A population-based study in Korea.
Topics: Adolescent; Adult; Bayes Theorem; Child; Cross-Sectional Studies; Dyslipidemias; Endocrine Disruptor | 2022 |
Urine Levels of Phthalate Metabolites and Bisphenol A in Relation to Main Metabolic Syndrome Components: Dyslipidemia, Hypertension and Type 2 Diabetes. A Pilot Study.
Topics: Benzhydryl Compounds; Biomarkers; Chromatography, High Pressure Liquid; Czech Republic; Diabetes Mel | 2016 |